Top compounds associated with response to ACSM5


Feature Type Standardized
Nominal ANOVA
mRNA tivantinib CTRPv2 pan-cancer AAC -0.034 0.4
mRNA tivozanib CTRPv2 pan-cancer AAC 0.034 0.4
mRNA tivozanib GDSC1000 pan-cancer AAC 0.016 0.6
mRNA tosedostat CTRPv2 pan-cancer AAC 0.046 0.2
mRNA tretinoin:carboplatin (2:1 mol/mol) CTRPv2 pan-cancer AAC 0.018 0.6
mRNA tretinoin:navitoclax (4:1 mol/mol) CTRPv2 pan-cancer AAC 0.082 0.02
mRNA triazolothiadiazine CTRPv2 pan-cancer AAC -0.014 0.7
mRNA trifluoperazine CTRPv2 pan-cancer AAC -0.062 0.1
mRNA triptolide CTRPv2 pan-cancer AAC 0.0063 0.9
mRNA tubastatin A CTRPv2 pan-cancer AAC 0.011 0.8
Download CSV